This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit June 26, 2014

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click here to view an article on the attempts to solve prescription drug abuse while protecting access for people with pain.

A new Biodesix study highlights VeriStrat’s ability to predict differential treatment outcomes between erlotinib and chemotherapy for non-small cell lung cancer.

Click here to read the press release!

Get up to date information on nutrition and nutrition research from Michael Greger, M.D. at NutritionFacts.org. Click here to view the website!

Granix is now available in the fight against neutropenia during chemotherapy. Click here to view the USPI! Visit www.granixrx.com for more information.

Click here to view the following free CME/CEU program:
Non-Invasive Pre Natal Testing: What Managed Care Needs to Know

Click Here to view the Journal of Managed Care Medicine

Click Here to view our Complimentary Online CME/CEU Webcasts


Announcing the NAMCP Medical Directors Breast Cancer Resource Center. Click here to visit the website.

The Academy of Oncology Nurse Navigators white paper, "Assessing the Creative Application and Usefulness of NSider: A Tactical Tool for the Oncology Nurse Navigator" was published in the journal, The Oncology Nurse-APN/NP.

Click here to view the white paper.


 




GENOMICS

In single gene, a path to fight heart attacks
The New York Times
Two major studies by leading research groups published independently identified mutations in a single gene that protect against heart attacks by keeping levels of triglycerides — a kind of fat in the blood — very low for a lifetime. The findings are expected to lead to a push to develop drugs that mimic the effect of the mutations, potentially offering the first new class of drugs to combat heart disease in decades, experts say.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Genes tied to curvature of spine in kids
HealthDay News
Scientists say they've identified two rare genetic mutations that greatly increase a child's risk for severe scoliosis — curvature of the spine. Children with these mutations have a quadrupled risk of developing S-shaped curves in their spines that are serious enough to require surgery, according to the team at Washington University School of Medicine in St. Louis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Cancer genes hijack enhancers
Medical Xpress
Unlike most other forms of cancer, medulloblastomas exhibits very few mutations in growth-promoting genes. In collaboration with an international team of colleagues, scientists from the German Cancer Research Center have now made an important discovery about a particularly malignant subgroup of medulloblastomas: often the cancer-causing genes are transcribed at higher or lower levels than normal.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


SPONSORED CONTENT


ACCOUNTABLE CARE ORGANIZATIONS


Aetna: ACOs need data sharing, mobile health
FierceHealthPayer
While it will take several years to measure the true effect of accountable care organizations, investments in technology and data sharing could accelerate the model's success. Aetna's CEO of Accountable Care Solutions Charles Kennedy. M.D., offered his two cents on overcoming ACO challenges in a recent interview.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


ACO initiatives test pharma's traditional sales model
Forbes
The U.S. healthcare system's shift from volume to value-based reimbursement for treatment in order to lower costs and improve patient care is disrupting healthcare business models. The high-profile government–led accountable care organizations, which put financial pressure on payers and providers to share responsibility for meeting quality and cost goals, is no exception.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


BIOTECH/DIAGNOSTICS/PERSONALIZED MEDICINE


Personalized medicine is here, but is your doctor ready to use the new genome sequencing technologies?
Medical Daily
The Human Genome Project was completed in 2003, and in the decade-plus since then, clinical genome and exome sequencing has gradually moved into mainstream medical practice. Yet, confusion remains, certainly among physicians, as to when they should order these tests, how to interpret the results, and most importantly, what information should be conveyed to their patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Aging accelerates genomic changes, signaling challenges for personalized medicine
Science Codex
Exploiting individual genomes for personalized medicine may be more complicated than medical scientists have suspected, researchers at the Virginia Bioinformatics Institute of Virginia Tech have discovered. In a paper published in June in the journal Aging, scientists from the institute's Medical Informatics and Systems Division found that spontaneous mutations occur in our bodies constantly, but the rate of change differed dramatically among various people.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  CEUS: RN, CCM, Safety Training

Get CEUs and Safety Training for your Nurses and Case Managers! Group rates available! CareerSmart offers online CEUs and safety training applicable for Nurses, Case Managers and other healthcare professionals. They are designed to help staff prevent work-related injuries and maintain compliance with mandated continuing education requirements.
 


REGENERATIVE MEDICINE


Stem cell transplantation for severe sclerosis associated with improved long-term survival
Medical Xpress
Among patients with a severe, life-threatening type of sclerosis, treatment with hematopoietic stem cell transplantation, compared to intravenous infusion of the chemotherapeutic drug cyclophosphamide, was associated with an increased treatment-related risk of death in the first year, but better long-term survival, according to a study in JAMA.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Osteoarthritis may be treated with stem cell mobilization therapy
News-Medical.net
Researchers in Taiwan have found that peripheral blood stem cells can be "mobilized" by injection of a special preparation of granulocyte colony-stimulating factor into rats that modeled osteoarthritis. The bone marrow was stimulated to produce stem cells, leading to the inhibition of OA progression. The finding, they said, may lead to a more effective therapy for OA, a common joint disease that affects 10 percent of Americans over the age of 60.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
What is Solesta?

What does a good day mean for your patients?

LEARN MORE
Advertise here!

To find out how to feature your company in the GBEMTI eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.
MORE


EMERGING MEDICAL TECHNOLOGIES


Neurobridge device allows quadriplegic to move his own hand
CNET
Ian Burkhart, a 23-year-old quadriplegic from Dublin, Ohio, was injured in 2010 in a diving accident, breaking his neck on a sandbar and paralyzing his body from the neck down. He has some use of his arms, but was left unable to move his legs, hands and fingers. Thanks to a new device known as the Neurobridge, though, Burkhart has now moved his right hand and fingers for the first time since the accident — signalling a brighter future for paralysis patients.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Study: Patients more honest, open with virtual doctors
iHealthBeat
Patients are more comfortable discussing private health matters with a "virtual human," or computer-created entity, according to a new study published in the journal Computers in Human Behavior, Pacific Standard Magazine reports. For the study — which was led by Gale Lucas of the University of Southern California's Institute for Creative Technologies — researchers recruited online 239 adults.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE




FEATURED ARTICLE
TRENDING ARTICLE
MOST POPULAR ARTICLE
In single gene, a path to fight heart attacks
The New York Times
Two major studies by leading research groups published independently identified mutations in a single gene that protect against heart attacks by keeping levels of triglycerides — a kind of fat in the blood — very low for a lifetime.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
Alternatives to ACO strategies emerge
HealthLeaders Media
While joining an ACO can be the right decision for some physicians practices, the cost savings under this model are still being tested.

Share on FacebookTwitterShare on LinkedinE-mail article
read more
How our genes could make us gay or straight
The Washington Post
The claim that homosexual men share a "gay gene" created a furor in the 1990s. But new research two decades on supports this claim — and adds another candidate gene.

Share on FacebookTwitterShare on LinkedinE-mail article
read more


MANAGED HEALTHCARE NEWS


Making the case for state Medicaid expansion
By Maria Frisch
Medicaid is a joint federal- and state-funded program that provides healthcare for more than 60 million low-income Americans. As a result of the Affordable Care Act, Medicaid was expanded to cover people from 19 to 65 years old with incomes of no more than 138 percent of the federal poverty level. But not all states are taking part in the expansion. This article makes a case in support of state-level Medicaid expansion, by examining health and financial factors. However, it is also important to consider the ethical and political factors at play. The matter is complex, and there are no easy answers.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Jumping through hoops for a better health plan
The New York Times
To get an idea of what your employer's health plan may look like in the near future, consider the options the government of Manatee County, Florida, offers to its workers. The county, on the state's west coast, offers four different plans that charge members the same monthly premium — currently $70 for a single employee. Everyone paying that amount is eligible for a "basic" plan that carries a $1,000 deductible — the amount you must pay before the plan starts paying — for hospital coverage.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


2014 premiums were $100 or less; 2015 looks promising
USA Today
Nearly 70 percent of consumers who bought subsidized health insurance on the federal exchange for 2014 paid $100 or less in monthly premiums, a federal report shows. That means the average monthly premium went from $346 before tax credits to $82 across all plan types, according to the Department of Health and Human Services report.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA: NEW TREATMENTS AND TECHNOLOGY


FDA: A new posture in digital health?
Modern Healthcare
If there is any government agency viewed with suspicion and mistrust in Silicon Valley, it's the Food and Drug Administration. The agency's reputation among the valley's tech heads is a bad one — a stodgy, slow-moving agency officially concerned with high quality and safety. For a region that celebrates speed and, yes, even failure, no philosophy could be more opposed.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Testosterone products must warn about clot risk
HealthDay News via WebMD
The growing unease around the safety of testosterone supplements was highlighted with a U.S. Food and Drug Administration announcement that the products must now carry a warning label on the general risk of blood clots in the veins. Testosterone therapy has been widely advertised as a way to help aging men with so-called "low T" improve their sex drive and reclaim diminished energy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FDA approves Sivextro to treat skin infections
FDA.gov
The U.S. Food and Drug Administration approved Sivextro, a new antibacterial drug, to treat adults with skin infections. Sivextro is approved to treat patients with acute bacterial skin and skin structure infections caused by certain susceptible bacteria, including Staphylococcus aureus, various Streptococcus species, and Enterococcus faecalis. Sivextro is available for intravenous and oral use.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


FAST FACTS
"Seizures can be caused by a number of factors, including epilepsy or fever, and most seizures stop themselves, according to the National Institutes of Health."


TRENDING ARTICLES
Missed last week's issue? See which articles your colleagues read most.

    Newly discovered mechanism could regulate gene activity (Phys.org)
'Good health' genes linked to increased risk of brain cancer (LiveScience)
3 ACO lessons from integrated systems (FierceHealthPlayer)
Embryonic stem cells offer promising treatment for multiple sclerosis (redOrbit)
ACOs, digital health companies petition new HHS secretary to derestrict telehealth (mobihealthnews)
ICD-10: Everything you need to know (By Maria Frisch)

Don't be left behind. Click here to see what else you missed.
 

Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2635
Download media kit

Natalie Rodriguez, Senior Content Editor, 469.420.2635   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
June 19, 2014
June 12, 2014
June 5, 2014
May 29, 2014



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063